These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 21232035)
1. Astragaloside IV synergizes with ferulic acid to inhibit renal tubulointerstitial fibrosis in rats with obstructive nephropathy. Meng LQ; Tang JW; Wang Y; Zhao JR; Shang MY; Zhang M; Liu SY; Qu L; Cai SQ; Li XM Br J Pharmacol; 2011 Apr; 162(8):1805-18. PubMed ID: 21232035 [TBL] [Abstract][Full Text] [Related]
2. Astragaloside IV inhibits renal tubulointerstitial fibrosis by blocking TGF-β/Smad signaling pathway in vivo and in vitro. Wang L; Chi YF; Yuan ZT; Zhou WC; Yin PH; Zhang XM; Peng W; Cai H Exp Biol Med (Maywood); 2014 Oct; 239(10):1310-24. PubMed ID: 24879422 [TBL] [Abstract][Full Text] [Related]
3. Astragaloside IV synergizes with ferulic acid to suppress hepatic stellate cells activation in vitro. Dong H; Guo H; Liang Y; Wang X; Niu Y Free Radic Res; 2017 Feb; 51(2):167-178. PubMed ID: 28147890 [TBL] [Abstract][Full Text] [Related]
4. Pirfenidone suppresses MAPK signalling pathway to reverse epithelial-mesenchymal transition and renal fibrosis. Li Z; Liu X; Wang B; Nie Y; Wen J; Wang Q; Gu C Nephrology (Carlton); 2017 Aug; 22(8):589-597. PubMed ID: 27245114 [TBL] [Abstract][Full Text] [Related]
5. Astragaloside IV Synergizes with Ferulic Acid to Alleviate Hepatic Fibrosis in Bile Duct-Ligated Cirrhotic Rats. Zhao XM; Zhang J; Liang YN; Niu YC Dig Dis Sci; 2020 Oct; 65(10):2925-2936. PubMed ID: 31900718 [TBL] [Abstract][Full Text] [Related]
6. Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. Rhyu DY; Yang Y; Ha H; Lee GT; Song JS; Uh ST; Lee HB J Am Soc Nephrol; 2005 Mar; 16(3):667-75. PubMed ID: 15677311 [TBL] [Abstract][Full Text] [Related]
7. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation. Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688 [TBL] [Abstract][Full Text] [Related]
8. Fluorofenidone attenuates tubulointerstitial fibrosis by inhibiting TGF-β(1)-induced fibroblast activation. Yuan Q; Wang R; Peng Y; Fu X; Wang W; Wang L; Zhang F; Peng Z; Ning W; Hu G; Wang Z; Tao L Am J Nephrol; 2011; 34(2):181-94. PubMed ID: 21791914 [TBL] [Abstract][Full Text] [Related]
9. Astragaloside IV ameliorates renal fibrosis via the inhibition of mitogen-activated protein kinases and antiapoptosis in vivo and in vitro. Xu W; Shao X; Tian L; Gu L; Zhang M; Wang Q; Wu B; Wang L; Yao J; Xu X; Mou S; Ni Z J Pharmacol Exp Ther; 2014 Sep; 350(3):552-62. PubMed ID: 24951279 [TBL] [Abstract][Full Text] [Related]
12. Paclitaxel attenuates renal interstitial fibroblast activation and interstitial fibrosis by inhibiting STAT3 signaling. Zhang L; Xu X; Yang R; Chen J; Wang S; Yang J; Xiang X; He Z; Zhao Y; Dong Z; Zhang D Drug Des Devel Ther; 2015; 9():2139-48. PubMed ID: 25931810 [TBL] [Abstract][Full Text] [Related]
13. Astragaloside IV attenuates high glucose-induced EMT by inhibiting the TGF-β/Smad pathway in renal proximal tubular epithelial cells. Wang YN; Zhao SL; Su YY; Feng JX; Wang S; Liao XM; Wang LN; Li JC; Meng P; Li HY; Zhang YF Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32515466 [TBL] [Abstract][Full Text] [Related]
14. Delayed administration of suramin attenuates the progression of renal fibrosis in obstructive nephropathy. Liu N; Tolbert E; Ponnusamy M; Yan H; Zhuang S J Pharmacol Exp Ther; 2011 Sep; 338(3):758-66. PubMed ID: 21622732 [TBL] [Abstract][Full Text] [Related]
15. [Investigate the effects of compound radix notoginseng on renal interstitial fibrosis and kidney-targeting treatment]. Xie XS; Zuo C; Zhang ZY; Liu HC; Feng SG; Zhang CL; Yuan W; Fan JM Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Jan; 43(1):28-33. PubMed ID: 22455126 [TBL] [Abstract][Full Text] [Related]
16. [Prohibitin suppresses renal interstitial fibroblasts proliferation and phenotypic change induced by transforming growth factor-beta1]. Guo W; Xu H; Huang WY; Chen J; Yang Y; Fu R; Liu HM; Zha XL; Zhang ZG Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(24):1660-5. PubMed ID: 17825142 [TBL] [Abstract][Full Text] [Related]
17. Glycolysis inhibitors suppress renal interstitial fibrosis via divergent effects on fibroblasts and tubular cells. Wei Q; Su J; Dong G; Zhang M; Huo Y; Dong Z Am J Physiol Renal Physiol; 2019 Jun; 316(6):F1162-F1172. PubMed ID: 30969803 [TBL] [Abstract][Full Text] [Related]
18. Lefty-1 alleviates TGF-β1-induced fibroblast-myofibroblast transdifferentiation in NRK-49F cells. Zhang L; Zhang J; Xu C; Zhou X; Wang W; Zheng R; Hu W; Wu P Drug Des Devel Ther; 2015; 9():4669-78. PubMed ID: 26316705 [TBL] [Abstract][Full Text] [Related]
19. Preventive effects and mechanisms of rhein on renal interstitial fibrosis in obstructive nephropathy. He D; Lee L; Yang J; Wang X Biol Pharm Bull; 2011; 34(8):1219-26. PubMed ID: 21804209 [TBL] [Abstract][Full Text] [Related]
20. Melatonin ameliorates renal fibroblast-myofibroblast transdifferentiation and renal fibrosis through miR-21-5p regulation. Li N; Wang Z; Gao F; Lei Y; Li Z J Cell Mol Med; 2020 May; 24(10):5615-5628. PubMed ID: 32243691 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]